Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection

Area of Science:

• Immunology
• Microbiology
• Pathogenesis

Background:

• Burkholderia mallei causes severe, life-threatening pneumonia in equids and humans.
• The role of chemokines, like MCP-1, in early immune responses to B. mallei pulmonary infection is poorly understood.
• Previous studies focused on MCP-1 in gram-positive infections, leaving its role in gram-negative pneumonia unexamined.

Purpose of the Study:

• To investigate the role of MCP-1 and its receptor CCR2 in the host immune response to pneumonic B. mallei infection.
• To determine the impact of MCP-1 deficiency on cellular recruitment and cytokine production in the lungs during B. mallei infection.

Main Methods:

• Utilized a mouse model of pneumonic B. mallei infection.
• Compared disease progression, bacterial burden, and immune cell infiltration in wild-type (WT), MCP-1(-/-), and CCR2(-/-) mice.
• Assessed the production of key cytokines, including IL-12 and IFN-gamma.
• Investigated the effect of IFN-gamma treatment in CCR2(-/-) mice.

Main Results:

• MCP-1(-/-) and CCR2(-/-) mice exhibited extreme susceptibility to B. mallei pulmonary infection compared to WT mice.
• CCR2(-/-) mice showed increased bacterial burden and organ lesions, with reduced monocyte and dendritic cell lung recruitment but increased neutrophil infiltration.
• Depletion of monocytes/macrophages in WT mice also increased susceptibility.
• Impaired production of IL-12 and IFN-gamma was observed in MCP-1(-/-) and CCR2(-/-) mice.
• Recombinant IFN-gamma treatment restored protection in CCR2(-/-) mice against lethal B. mallei challenge.

Conclusions:

• MCP-1 plays a critical role in orchestrating cellular immunity and IFN-gamma production during pneumonic B. mallei infection.
• The MCP-1/CCR2 pathway is essential for protective immunity against this gram-negative bacterial pneumonia.
• Findings suggest MCP-1's importance in other gram-negative pneumonias.